Tribun Health has entered into a strategic partnership with Ibex Medical Analytics to integrate Ibex’s advanced AI-powered diagnostic tools into the CaloPix® Information Management System (IMS).

This collaboration aims to provide healthcare providers worldwide with access to cutting-edge AI technology.

Under the partnership, Tribun Health will offer Ibex’s AI solutions for multiple tissue types, including prostate, breast, and gastric, as part of the CaloPix® IMS platform.

These AI tools are designed to enhance the accuracy and efficiency of cancer detection and diagnosis in clinical practice.

The integration of Ibex's AI capabilities within the CaloPix® IMS allows pathologists to manage cases more effectively and access diagnostic results within their existing workflows.

This development addresses the growing need for AI-driven solutions that improve diagnostic precision, streamline patient care processes, and enhance overall healthcare outcomes.

The partnership represents a significant advancement in the adoption of AI in healthcare, with the combined solution set to be offered in Canada, the European Union, and the United States.

Tribun Health’s AI strategy is centered on three core areas: the development of proprietary algorithms optimized for workflow efficiency and diagnostic precision, strategic collaborations with AI leaders like Ibex, and the creation of an API that supports the integration of third-party and custom-developed algorithms.

This approach ensures that pathology labs have access to a comprehensive AI-powered ecosystem tailored to their specific needs.




Source: tribun.health

Report Abuse